
New release of new coronavirus antigen test kit “COVID-19 Ag”
Applying high-sensitivity detection technology by silver salt amplification reaction For infectious disease testing device “Fuji Dry Chem IMMUNO AG” series
FUJIFILM Corporation (President: Kenji Sukeno) has announced a new coronavirus (SARS-CoV-2) antigen test kit “Fuji Dry Chem IMMUNO AG” that applies high-sensitivity detection technology based on the silver salt amplification reaction used in the photo development process. In vitro diagnosis of the cartridge COVID-19 Ag (hereinafter, “COVID-19 Ag”) for our infectious disease testing device “Fuji Dry Chem IMMUNO AG” (hereinafter, IMMUNO AG) series. It will be released as a pharmaceutical product through FUJIFILM Medical Co., Ltd. (President: Yoshihiro Kawahara) from March 9th.
With the spread of the new coronavirus infection (COVID-19), the scope of antigen qualitative testing has been expanded in Japan from January 22, 2021. As a result, the antigen qualitative test, which was previously defined as 2 to 9 days after onset, is now possible from 1 to 9 days after onset. In addition, when it is difficult to carry out a PCR test in an area where infection has spread, it is effective to carry out a wide range of antigen qualitative tests at medical institutions and facilities for the elderly, which are often at high risk of aggravation, from the viewpoint of preventing the spread of infection. Since the Ministry of Health, Labor and Welfare has indicated that, it has become possible to carry out qualitative antigen tests as an administrative test for staff of medical institutions and facilities for the elderly, inpatients and residents, even if they are asymptomatic. * 1 . In the future, it is expected that antigen qualitative tests, which can be easily tested, will be performed in more situations, but in general, their sensitivity was lower than that of PCR tests, so higher sensitivity was required. Read More



